Legend Biotech Corp ADRLEGN
Price$19.32

Financial Snapshot

Revenue, profitability, returns, debt, and capital allocation

Revenue $627.2M+120.0% YoYTTM through 30 Sep 2025
Net Income -$296.8MTTM through 31 Mar 2025
Free Cash Flow -$128.8MTTM through 31 Dec 2025

Margins

Current
Gross Margin60.3%
Operating Margin-13.3%
Net Margin-47.3%

Returns

-29.6%ROE
-17.1%ROA

Balance Sheet Health

Debt / Equity0.00x
Current Ratio1.96x
Net Debt-$901.9Mnet cash position
Cash & Equivalents$901.9M

Quality Metrics

Piotroski F-Score3 / 9
FCF Margin-20.5%
Earnings-Beat Rate33.3%

Multi-Year Trend

Revenue
'18'19'20'21'22'23'24
FY2024: $627.2M
Diluted EPS
'19'20'21'22'23'24'25
FY2025: $-0.81

Dividend

No dividend

Capital Allocation

Capex Intensity4.6%
All values are periodic snapshots, not live quotes. Source dates are shown for reference.

Filing Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up
AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.